TrialClinical trialPHN-02652025-12-11 18:00 CT
FRDA Investigator Initiated Study (IIS) With Elamipretide
Source · ClinicalTrials.gov: elamipretide
TLDR
ClinicalTrials.gov lists an investigator-initiated study of Elamipretide for vision loss in Friedreich Ataxia (FRDA) as completed. The study aimed to evaluate safety, tolerability, and activity; the provided excerpt does not report results.
01—Key points
- 01The study is listed as completed.
- 02Investigators aimed to evaluate Elamipretide for FRDA-related vision loss.
- 03No safety or activity findings are provided in the excerpt.
Why it matters Editorial
The listing documents a completed clinical investigation of Elamipretide but does not establish its safety or benefit for FRDA-related vision loss.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
02—Related news
Trial
PHN-0262
2026-10-26 19:00 CT
An Intermediate Size Expanded Access Protocol of Elamipretide
ClinicalTrials.gov: elamipretide
Trial
PHN-0263
2026-09-16 19:00 CT
Clinical Trial in Patients With Barth Syndrome- 4TAZPower
ClinicalTrials.gov: elamipretide
Trial
PHN-0264
2026-09-16 19:00 CT
Trial
PHN-0266
2025-12-09 18:00 CT
Study of Healthy Aging and Physical Function With Elamipretide
ClinicalTrials.gov: elamipretide
Trial
PHN-0267
2025-10-23 19:00 CT